September 20, 2018

New Study Finds Acetaminophen May Double Risk Of Asthma In Children

NEWS A new study has found giving young children medicines containing acetaminophen (paracetamol) may double their risk of developing asthma in later life. COMMENT The publication […]
September 19, 2018

How Overmedication Is Injuring And Killing The Elderly

NEWS New research shows that elderly people taking multiple high-risk drugs for sleeping, pain or incontinence are twice as likely as others to fall and break […]
September 12, 2018

Prominent Cancer Researcher Fails To Disclose Multimillion Dollar Financial Ties To Pharma

NEWS A prominent breast cancer doctor failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial […]
September 12, 2018

Common Painkiller Linked To Increased Risk Of Major Heart Problems

NEWS A study published in the British Medical Journal has found that the commonly used painkiller diclofenac, a so-called nonsteroidal anti-inflammatory drug (NSAID), is associated with […]
September 12, 2018

National Health Service In England To Offer Leukemia Treatment Costing $361,750 Per Patient

NEWS Health authorities in England have agreed to make a leukemia treatment with a colossal price tag of $361,750 per patient available for children. COMMENT Predictably […]
September 12, 2018

New Research Further Lowers Credibility Of Statins

NEWS New research from Spain has further lowered the credibility of statins, finding they are not effective at reducing heart disease and strokes in old or […]
September 5, 2018

Class-Action Lawsuit Takes Aim At Big Pharma Over Babies Exposed To Opioids

NEWS A Philadelphia law firm has filed a proposed class-action lawsuit against a number of opioid manufacturers, alleging they are responsible for the medical needs of […]
September 5, 2018

Doctors Treating Cancer Fail To Disclose Funding Received For Drug Trials

NEWS A new study has revealed that doctors treating cancer fail to disclose almost half of the funding they receive for clinical trials of cancer drugs. […]